Fate Therapeutics Inc (NASDAQ:FATE)

5.54
Delayed Data
As of 12:42pm ET
 +0.065 / +1.19%
Today’s Change
3.50
Today|||52-Week Range
7.69
+10.04%
Year-to-Date

Today’s Trading

Previous close5.47
Today’s open5.55
Day’s range5.41 - 5.58
Volume14,184
Average volume (3 months)37,488
Market cap$112.9M
Dividend yield--
Data as of 12:42pm ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)+64.12%
Earnings growth (this year)-1.31%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book3.97

Competitors

 Today’s
change
Today’s
% change
HSGXHistogenics Corp+0.08+0.95%
--ImmunoClin Corp0.000.00%
PSDVpSivida Corp+0.02+0.49%
AUPHAurinia Pharmaceutic...+0.35+9.26%
Data as of 12:55pm ET, 04/28/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$0.00
Annual profit (last year)-$25.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christian Weyer
Chief Financial &
Operating Officer
J. Scott Wolchko
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers